Showing 21 - 40 of 178 results
In space, without the protection of the magnetosphere, the type and dose of radiation is considerably different to what is naturally experienced on earth. However, it is the secondary particles of lower energies created when galactic and cosmic radiation interacts with shielding that is of concern for astronauts.
In collaboration with the French National Institute of Health and Medical Research (INSERM) and the French International Space Agency (CNES), ANSTO scientists are undertaking research on the radiobiological effects of secondary particles that are created when radiation interacts with the shielding on the International Space Station.
Winners of the Big Ideas Competition 2021
Two startups supported by the nandin Innovation Centre at ANSTO have hit the ground running in 2021 securing major opportunities from state governments to see their businesses thrive.
Lithium Australia, a company that has a close association with ANSTO’s business unit Minerals, has been awarded a US patent for its unique lithium mining technology SiLeach®.
Read about an ANSTO scientist and their work to prepare for a school project or interview.
A long-standing collaboration led biomedical researchers from the University of Sydney has recently achieved success with the recent announcement of an innovative bone implant that significantly reduces rejection and inflammation.
Frequently asked questions on the Mo-99 Manufacturing Facility and the ANSTO Nuclear Medicine project.
Blue Carbon Horizons Team showed coastal wetlands capture more carbon as sea levels rise
ANSTO environmental scientists contribute to investigation of carbon capture in wetlands.
The final report on the safety of Building 23 by the independent expert review team has been completed.
